 - Participants who have had a potent CYP1A2 metabolic inducer e.g., carbamazepine; rifampin or inhibitor e.g., amiodarone; cimetidine; efavirenz; fluoroquinolone antibiotics; ticlopidine added to andor removed from their medication regimen in the past two weeks 